Buprenorphine-naloxone (along with methadone) are both evidence-based recommended treatments for patients who are pregnant and struggle with dependence and addiction to opioids.
We encourage all patients to stay on medication for addiction treatment (MAT) during pregnancy—and you can take buprenorphine/naloxone (Suboxone) OR buprenorphine-monotherapy (Subutex) while pregnant. It was initially thought in the early use of buprenorphine/naloxone (Suboxone) that the naloxone component could cross the placenta and have negative consequences for the pregnancy. While the mono-product (Subutex) was previously the standard of care, this was only because all testing in pregnant patients occurred using this mono-product. However, over time and with further studies, the buprenorphine/naloxone (Suboxone) product has demonstrated that it is just as safe for mom as it is for the baby. Read more about buprenorphine use during pregnancy here.